Metabolic biomarkers in lung cancer screening and early diagnosis (Review)

Late diagnosis is one of the major contributing factors to the high mortality rate of lung cancer, which is now the leading cause of cancer-associated mortality worldwide. At present, low-dose CT (LDCT) screening in the high-risk population, in which lung cancer incidence is higher than that of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yongjie, Dong, Xuesi, Qin, Chao, Wang, Fei, Cao, Wei, Li, Jiang, Yu, Yiwen, Zhao, Liang, Tan, Fengwei, Chen, Wanqing, Li, Ni, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193366/
https://www.ncbi.nlm.nih.gov/pubmed/37216157
http://dx.doi.org/10.3892/ol.2023.13851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193366/
https://www.ncbi.nlm.nih.gov/pubmed/37216157
http://dx.doi.org/10.3892/ol.2023.13851

Ejemplares similares